Bloomfield, New Jersey — Bloomfield, New Jersey

Bloomfield, New Jersey is a clinical research site located in Bloomfield, New Jersey, United States 07003.

Crixeo Health Trust Score: 64/100 (FAIR). This profile has not yet been claimed by the site owner.

Bloomfield, New Jersey has participated in 3 clinical trials with 2 currently active.

Therapeutic areas: Neurotrophic Keratopathy, Diabetic Macular Edema (DME), Neovascular Age-related Macular Degeneration (NVAMD).

Sponsors: Oyster Point Pharma, Inc., EyeBiotech Ltd..

Sponsor Feasibility Report

Trust Score: 64/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Bloomfield, New Jersey?

Bloomfield, New Jersey has a Crixeo Trust Score of 64/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Bloomfield, New Jersey conducted?

Bloomfield, New Jersey has 3 clinical trials on record, with 2 currently active. Their work covers Neurotrophic Keratopathy, Diabetic Macular Edema (DME), Neovascular Age-related Macular Degeneration (NVAMD).

Is Bloomfield, New Jersey accredited by Crixeo Health?

Bloomfield, New Jersey has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Bloomfield, New Jersey?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.